Evidence map›Paper›PMID 36420272›Full record

ArticleFrontiers in immunology2022

Dendritic cell-specific transmembrane protein is required for synovitis and bone resorption in inflammatory arthritis.

Maria de la Luz Garcia-Hernandez, Javier Rangel-Moreno, Maricela Garcia-Castaneda, H Mark Kenney, Ananta Paine, Michael Thullen, Allen P Anandarajah, Edward M Schwarz, Robert T Dirksen, Christopher T Ritchlin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. The gut-bone-inflammation axis: intestinal barrier disruption as a central driver of osteoporosis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Research progress on the role of dendritic cells in immune metabolism of rheumatoid arthritis].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2024
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Maria de la Luz Garcia-HernandezDivision of Allergy/Immunology and Rheumatology, University of Rochester, Rochester, NY, United States.
Javier Rangel-MorenoDivision of Allergy/Immunology and Rheumatology, University of Rochester, Rochester, NY, United States.
Maricela Garcia-CastanedaDepartment of Pharmacology and Physiology (SMD), University of Rochester Medical Center, Rochester, NY, United States.
H Mark KenneyCenter for Musculoskeletal Research. University of Rochester, Rochester, NY, United States.
Ananta PaineDivision of Allergy/Immunology and Rheumatology, University of Rochester, Rochester, NY, United States.
Michael ThullenCenter for Musculoskeletal Research. University of Rochester, Rochester, NY, United States.
Allen P AnandarajahDivision of Allergy/Immunology and Rheumatology, University of Rochester, Rochester, NY, United States.
Edward M SchwarzCenter for Musculoskeletal Research. University of Rochester, Rochester, NY, United States.
Robert T DirksenDepartment of Pharmacology and Physiology (SMD), University of Rochester Medical Center, Rochester, NY, United States.
Christopher T RitchlinDivision of Allergy/Immunology and Rheumatology, University of Rochester, Rochester, NY, United States.
University of Rochester · USUniversity of Rochester Medical Center · US

Funding

ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSISR01AI111914 · NIAID · WASHINGTON UNIVERSITY · PI KAUSHAL, DEEPAK, KHADER, SHABAANA A. · 2015 to 2025
$11.1M
Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)P30AR069655 · NIAMS · UNIVERSITY OF ROCHESTER · PI Edward M. Schwarz · 2016 to 2026
$7.8M
Elucidating the Mechanisms of Arthritic Flare and Developing TreatmentsR01AR056702 · NIAMS · UNIVERSITY OF ROCHESTER · PI SCHWARZ, EDWARD M. · 2009 to 2025
$4.9M
Molecular Mechanism and Functional Role of SOCE in Skeletal MuscleR01AR059646 · NIAMS · UNIVERSITY OF ROCHESTER · PI DIRKSEN, ROBERT T · 2010 to 2020
$3.6M
Pathophysiology and Treatment of Recessive RYR1 Related MyopathyR01AR078000 · NIAMS · UNIVERSITY OF ROCHESTER · PI JAMES J DOWLING, Robert T Dirksen · 2020 to 2026
$2.7M
NIAID NIH HHS R01 AI111914NIAMS NIH HHS P30 AR069655NIAMS NIH HHS R01 AR056702NIAMS NIH HHS R01 AR059646NIAMS NIH HHS R01 AR078000
6 · The paper itself

Abstract

Objective: Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) is essential for the formation of fully functional multinucleated osteoclasts. DC-STAMP deficient mice, under physiological conditions, exhibit osteopetrosis and develop systemic autoimmunity with age. However, the function of DC-STAMP in inflammation is currently unknown. We examined whether genetic ablation of DC-STAMP attenuates synovitis and bone erosion in TNF transgenic (Tg) and K/BxN serum-induced murine rheumatoid arthritis. Methods: We evaluated arthritis onset in Tg(hTNF) mice lacking DC-STAMP and 50:50 chimeric mice by visual examination, measurement of ankle width, micro-CT-scan analysis and quantitation of the area occupied by osteoclasts in bone sections. To further investigate the cellular and molecular events modulated by DC-STAMP, we measured serum cytokines, determined changes in cytokine mRNA expression by monocytes activated with IL4 or LPS/IFNγ and enumerated immune cells in inflamed mouse joints. Results: Synovitis, bone loss and matrix destruction are markedly reduced in Dcstamp Conclusion: These results reveal that DC-STAMP modulates both bone resorption and inflammation and may serve as an activity biomarker and therapeutic target in inflammatory arthritis and metabolic bone disease.

Indexed as

Arthritis, RheumatoidBone ResorptionSynovitisAnimalsCytokinesDendritic CellsInflammationMembrane ProteinsMiceCytokinesMembrane Proteinsarthritis mouse modelCCL2DC-STAMPTNFtype 2 cytokines

Identifiers

PMID36420272
PMCPMC9677122
OpenAlexW4308430352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.